Table 1. SILAC-labelled samples from supplementary material Fig. S2A were analyzed by Orbitrap MS
Fold ratio
ResidueIGF1/SSPI-103/SSIGF1/PI-103PMA/SSGö6983/SSPMA/Gö6983
Ser194.190.825.123.710.3112.10
Ser801.801.061.6915.770.10165.78
Ser821.221.40.888.730.07125.11
Ser1131.080.821.32---
Ser116---0.860.771.11
Ser1351.151.160.991.260.831.52
Ser1451.632.210.741.240.572.17
  • Data were quantified using MaxQuant (version 13.13.10) and are presented as a fold ratio of indicated treatments. SS, serum-starved conditions.